{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:45:41Z","timestamp":1793403941480,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.neurobiolaging.2021.05.012","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T01:23:42Z","timestamp":1625275422000},"page":"12-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction"],"prefix":"10.1016","volume":"106","author":[{"given":"Renee C","family":"Gentzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Toolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-0036","authenticated-orcid":false,"given":"Joel B","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-1731","authenticated-orcid":false,"given":"Philipp J","family":"Kahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob N","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0001","doi-asserted-by":"crossref","first-page":"11116","DOI":"10.1073\/pnas.1903054116","article-title":"Synapsins regulate alpha-synuclein functions","volume":"116","author":"Atias","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.02.004","article-title":"Long-term polarization of microglia upon alpha-synuclein overexpression in nonhuman primates","volume":"208","author":"Barkholt","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0003","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of alpha-synuclein in Parkinson's disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0004","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of alpha-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","article-title":"Microglial activation and antioxidant responses induced by the Parkinson's disease protein alpha-synuclein","volume":"8","author":"Beraud","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson's disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0007","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.3233\/JPD-179001","article-title":"Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff","volume":"7","author":"Braak","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0008","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/nbdi.2000.0286","article-title":"Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies","volume":"7","author":"Campbell","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0009","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14802\/jmd.19046.e","article-title":"Modeling alpha-synuclein propagation with preformed fibril injections","volume":"13","author":"Chung","year":"2020","journal-title":"J Mov Disord"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0011","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0012","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nbt.2959","article-title":"Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping","volume":"32","author":"de Vree","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0013","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0014","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/cne.24468","article-title":"Sensitivity and specificity of phospho-Ser129 alpha-synuclein monoclonal antibodies","volume":"526","author":"Delic","year":"2018","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12974-019-1636-8","article-title":"Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice","volume":"16","author":"Earls","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0017","doi-asserted-by":"crossref","first-page":"e00915","DOI":"10.1002\/brb3.915","article-title":"Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"8","author":"Ekmark-Lewen","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.12175","article-title":"Monoclonal antibodies selective for alpha-synuclein oligomers\/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation","volume":"126","author":"Fagerqvist","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/546462","article-title":"Four copies of SNCA responsible for autosomal dominant parkinson's disease in two italian siblings","author":"Ferese","year":"2015","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0021","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease","volume":"14","author":"George","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0023","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0024","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"Gorbatyuk","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0027","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","article-title":"Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease","volume":"799","author":"Hashimoto","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0028","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archneur.65.4.514","article-title":"Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia","volume":"65","author":"Ikeuchi","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0029","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.56.10.1355","article-title":"Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers","volume":"56","author":"Kruger","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0032","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 \u2013>Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0033","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of Parkinson's disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2014.05.009","article-title":"Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"69","author":"Lindstrom","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0036","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0037","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0038","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","article-title":"Prion-like acceleration of a synucleinopathy in a transgenic mouse model","volume":"33","author":"Mougenot","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0039","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","article-title":"Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders","volume":"299","author":"Nouraei","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0041","first-page":"562","article-title":"Subcellular fractionation","volume":"3","author":"Parisis","year":"2013","journal-title":"Materials Methods"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0042","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","article-title":"Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease","volume":"8","author":"Paumier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0043","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"Alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0044","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","article-title":"Best practices for generating and using alpha-synuclein pre-formed fibrils to model parkinson's disease in rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0045","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0046","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2017.12.001","article-title":"Suppression of autophagy in the brain of transgenic mice with overexpression of capital A, Cyrillic53capital TE, Cyrillic-mutant alpha-synuclein as an early event at synucleinopathy progression","volume":"672","author":"Pupyshev","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0047","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0048","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0049","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.1073\/pnas.1321785111","article-title":"Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice","volume":"111","author":"Sacino","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0050","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0051","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jnc.14139","article-title":"Prion-like' propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum","volume":"143","author":"Sargent","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0052","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"Schell","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0053","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","article-title":"Alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis","volume":"32","author":"Scott","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0054","series-title":"Fibrillar Abeta triggers microglial proteome alterations and dysfunction in Alzheimer mouse models","first-page":"9","author":"Sebastian Monasor","year":"2020"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0055","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0056","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","article-title":"Propagation of pathological alpha-synuclein in marmoset brain","volume":"5","author":"Shimozawa","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0057","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0058","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0059","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1073\/pnas.1903049116","article-title":"Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling","volume":"116","author":"Sun","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nbd.2011.09.017","article-title":"A30P alpha-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice","volume":"45","author":"Szego","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0061","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2012.04.012","article-title":"Impairment of the septal cholinergic neurons in MPTP-treated A30P alpha-synuclein mice","volume":"34","author":"Szego","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0062","first-page":"367","article-title":"Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders","volume":"152","author":"Takeda","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0063","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0064","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature16531","article-title":"Structural disorder of monomeric alpha-synuclein persists in mammalian cells","volume":"530","author":"Theillet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0065","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","article-title":"Synucleins regulate the kinetics of synaptic vesicle endocytosis","volume":"34","author":"Vargas","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0066","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0067","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0068","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated alpha-synuclein in Parkinson's disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0069","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0070","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2021.05.012_bib0071","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson's disease and multiple system atrophy have distinct alpha-synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J Biol Chem"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:38:20Z","timestamp":1759318700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":71,"alternative-id":["S0197458021001755"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.05.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}